Skip to content

Study of invasive fungal mould infections in intensive care units.

Invasive mould infections in Indian ICUs â?? descriptive epidemiology, management and outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/08/007212
Enrollment
300
Registered
2016-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Invasive mould infections

Interventions

None listed

Sponsors

MERCK SHARP DOHME CORP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A patient must fulfill the definition for a case, as given below. Proven case:Any host whose a) histopathology/ cytology/ direct microscopy demonstrates septate hyphae invading tissue or aspirate from sterile sites b) Culture is positive from sterile sites Probable case: Host satisfying criteria of EORTC definition/ Host with COPD satisfying definitions by Bulpa P, et al, Eur Resp J 2007;30:782â??800/ Host in ICU satisfying clinical algorithm by Blot SI, et al, Am J Resp Crit Care Med 2012 Apr 19

Exclusion criteria

Exclusion criteria: Patients with endemic mycoses (histoplasmosis, sporotrichosis, penicilliosis), yeast infections, and allergic fungal diseases like allergic bronchopulmonary aspergillosis will not be included. Infection limited to the skin only will also be excluded.

Design outcomes

Primary

MeasureTime frame
The incidence and clinical determinants of Invasive mould infections (IMIs) in Indian ICUs will be ascertainedTimepoint: 1 year

Secondary

MeasureTime frame
To determine the resistance to moulds, specific incidence in different patient groups.Timepoint: 1 year

Countries

India

Contacts

Public ContactArunaloke Chakrabarti

PGIMER

arunaloke@hotmail.com911722755173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026